
3 Grid Projects Company, Space Grade Precision Engineering Firm and Life Sciences Services Provider Stocks With a Strong Future Roadmap: Techno Electric & Engineering Company, MTAR Technologies and Indegene
Techno Electric & Engineering Company, MTAR Technologies and Indegene: ROE of 11.4% to 12.8% and FY22 to FY26 revenue CAGR of 20.7% to 31.0%. Prices as of 16 Nov 2026.
Updated: 17 Nov 2026 • 3:07 pm
Posted by:

Quick Answer
The three grid, space part and pharma service stocks to watch are Techno Electric & Engineering Company, MTAR Technologies and Indegene. Their return on equity ranges from 11.4% to 12.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 20.7% to 31.0%. Indegene has the highest return on equity at 12.8%, while Techno Electric & Engineering Company has the fastest revenue growth at 31.0% a year. Prices are based on the 16 November 2026 close, and this article is educational, not investment advice.
Grid, space part and pharma service stocks bring together companies with a visible plan for the years ahead. Techno Electric & Engineering Company, MTAR Technologies and Indegene cover a power transmission company, a precision engineering company and a life sciences services company.
This list covers three grid, space part and pharma service stocks with complete current figures: Techno Electric & Engineering Company, MTAR Technologies and Indegene. Every figure comes from the latest reported financials and the 16 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Grid, Space Part and Pharma Service Stocks?
Grid, space part and pharma service stocks are listed companies that build and run power transmission and substation projects and data centres, make precision parts for space, nuclear and clean energy, and offer commercial and clinical services to drug and device makers. Their earnings depend on grid orders, space and energy programmes and life science outsourcing.
Grid, Space Part and Pharma Service Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Techno Electric & Engineering Company | 955.15 | 10,943 | 25.4 | 22.7 | 11.4 | 0.02 |
| MTAR Technologies | 5,909 | 22,064 | 165.4 | 48.1 | 11.4 | 0.46 |
| Indegene | 662.4 | 14,454 | 36.0 | 59.2 | 12.8 | 0.05 |
On valuation, Indegene trades at a P/E below the industry P/E, while Techno Electric & Engineering Company and MTAR Technologies trade above it, which reflects the growth the market already expects. Readers comparing grid, space part and pharma service stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Grid, Space Part and Pharma Service Stocks Have a Strong Roadmap in India?
Grid, space part and pharma service stocks have a strong roadmap in India because large grid expansion plans, growing space and clean energy programmes and rising outsourcing by drug makers keep widening the market for these companies.
- Power transmission. Grids need new lines and substations.
- Precision engineering. Space and energy programmes need exact parts.
- Life sciences services. Drug makers outsource marketing work.
Why Techno Electric & Engineering Company Features Among These Grid, Space Part and Pharma Service Stocks
Among the grid, space part and pharma service stocks on this list, Techno Electric & Engineering Company builds power transmission and distribution infrastructure and also owns and operates wind power assets and data centre capacity.
In the June 2026 quarter, revenue grew 14.8% year on year to Rs 659 crore. Revenue rose from Rs 1,154 crore in FY22 to Rs 3,401 crore in FY26, a compound annual growth rate of 31.0%.
Net profit grew from Rs 239 crore in FY22 to Rs 449 crore in FY26, which works out to a compound annual growth rate of 17.0%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 10,943 crore. The stock trades at a P/E of 25.4, above the industry P/E of 22.7.
Roadmap: Strong demand for transmission networks and substations supports its engineering order book, while a new data centre platform opens a second growth path. Its operating wind assets add recurring cash flow.
What to watch: Watch the build-out of data centre capacity and the timing of large transmission orders.
Why MTAR Technologies Features Among These Grid, Space Part and Pharma Service Stocks
Among the grid projects, precision engineering and life science outsourcing shares on this list, MTAR Technologies is a Hyderabad-based maker of precision engineered components and assemblies for clean energy, nuclear, space and defence customers.
The company has a return on equity of 11.4%, a debt to equity ratio of 0.46 and a market capitalisation of Rs 22,064 crore. The stock trades at a P/E of 165.4, above the industry P/E of 48.1.
Revenue rose from Rs 331 crore in FY22 to Rs 899 crore in FY26, a compound annual growth rate of 28.4%. Net profit grew from Rs 60.9 crore in FY22 to Rs 94.0 crore in FY26, which works out to a compound annual growth rate of 11.5%.
Roadmap: The company supplies critical parts for fuel cell systems, space launch vehicles and nuclear power programmes, areas where qualification takes years and customer relationships are long-lasting. Added capacity and a growing order book support future revenue.
What to watch: Check order book execution in clean energy and the ramp-up of newly added capacity.
Why Indegene Features Among These Grid, Space Part and Pharma Service Stocks
Among the three companies on this list, Indegene is a Bengaluru-based healthcare technology and services company that helps biopharma and medical technology firms with commercial, medical and regulatory work using data and technology.
Revenue rose from Rs 1,690 crore in FY22 to Rs 3,582 crore in FY26, a compound annual growth rate of 20.7%. Net profit grew from Rs 163 crore in FY22 to Rs 401 crore in FY26, which works out to a compound annual growth rate of 25.3%.
In the June 2026 quarter, revenue grew 39.5% year on year to Rs 1,092 crore. The company has a return on equity of 12.8%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 14,454 crore. The stock trades at a P/E of 36.0, below the industry P/E of 59.2.
Roadmap: The company is widening its digital and artificial intelligence services for life sciences clients and adding new customers across drug and device makers. Multi-year contracts with global clients support recurring revenue.
What to watch: Monitor client additions, platform adoption and growth in artificial intelligence services.
Techno Electric & Engineering Company vs MTAR Technologies vs Indegene on Key Financials
The table below sets the three grid, space part and pharma service stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Techno Electric & Engineering Company | 1,154 | 3,401 | 31.0% | 449 | 13.2% |
| MTAR Technologies | 331 | 899 | 28.4% | 94.0 | 10.5% |
| Indegene | 1,690 | 3,582 | 20.7% | 401 | 11.2% |
Indegene posts the highest return on equity in this group at 12.8%. Indegene has the largest FY26 revenue at Rs 3,582 crore, and Techno Electric & Engineering Company shows the fastest revenue growth with a 31.0% compound annual rate. A useful habit with grid, space part and pharma service stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Grid, Space Part and Pharma Service Stocks
Every theme carries risks that deserve a check before any decision. For these grid, space part and pharma service stocks, the main points are: Long-term grid projects, precision engineering and life science outsourcing shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Government spending. Public project funding can shift between periods.
- Order timing. Project awards can shift between periods.
- Client spending. Technology budgets can vary with global conditions.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter grid, space part and pharma service stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Grid, Space Part and Pharma Service Stocks
Grid, space part and pharma service stocks suit investors who prefer to study business strength before price moves. Techno Electric & Engineering Company, MTAR Technologies and Indegene each have a clear plan to grow. Based on the 16 November 2026 close, Techno Electric & Engineering Company trades at Rs 955.15, MTAR Technologies at Rs 5,909 and Indegene at Rs 662.4. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these grid, space part and pharma service stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track grid, space part and pharma service stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are grid, space part and pharma service stocks?
Ans. Grid, space part and pharma service stocks are listed companies that build and run power transmission and substation projects and data centres, make precision parts for space, nuclear and clean energy, and offer commercial and clinical services to drug and device makers. Their earnings depend on grid orders, space and energy programmes and life science outsourcing. This list looks at three of them, Techno Electric & Engineering Company, MTAR Technologies and Indegene, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.
Which grid, space part and pharma service stocks are covered in this list?
Ans. This list covers Techno Electric & Engineering Company, MTAR Technologies and Indegene. Based on the 16 November 2026 close, Techno Electric & Engineering Company traded at Rs 955.15, MTAR Technologies at Rs 5,909 and Indegene at Rs 662.4. Their return on equity ranges from 11.4% to 12.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 20.7% to 31.0%.
Why do grid, space part and pharma service stocks have a strong future roadmap in India?
Ans. Grid, space part and pharma service stocks have a strong roadmap in India because large grid expansion plans, growing space and clean energy programmes and rising outsourcing by drug makers keep widening the market for these companies. The main drivers are as follows. Power transmission. Grids need new lines and substations. Precision engineering. Space and energy programmes need exact parts. Life sciences services. Drug makers outsource marketing work. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Techno Electric & Engineering Company performed financially?
Ans. Revenue rose from Rs 1,154 crore in FY22 to Rs 3,401 crore in FY26, a compound annual growth rate of 31.0%. Net profit grew from Rs 239 crore in FY22 to Rs 449 crore in FY26, which works out to a compound annual growth rate of 17.0%. In the June 2026 quarter, revenue grew 14.8% year on year to Rs 659 crore. The company has a return on equity of 11.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 10,943 crore. The stock trades at a P/E of 25.4, above the industry P/E of 22.7. Looking ahead, strong demand for transmission networks and substations supports its engineering order book, while a new data centre platform opens a second growth path. Its operating wind assets add recurring cash flow.
How has MTAR Technologies performed financially?
Ans. Revenue rose from Rs 331 crore in FY22 to Rs 899 crore in FY26, a compound annual growth rate of 28.4%. Net profit grew from Rs 60.9 crore in FY22 to Rs 94.0 crore in FY26, which works out to a compound annual growth rate of 11.5%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.46 and a market capitalisation of Rs 22,064 crore. The stock trades at a P/E of 165.4, above the industry P/E of 48.1. Looking ahead, the company supplies critical parts for fuel cell systems, space launch vehicles and nuclear power programmes, areas where qualification takes years and customer relationships are long-lasting. Added capacity and a growing order book support future revenue.
How has Indegene performed financially?
Ans. Revenue rose from Rs 1,690 crore in FY22 to Rs 3,582 crore in FY26, a compound annual growth rate of 20.7%. Net profit grew from Rs 163 crore in FY22 to Rs 401 crore in FY26, which works out to a compound annual growth rate of 25.3%. In the June 2026 quarter, revenue grew 39.5% year on year to Rs 1,092 crore. The company has a return on equity of 12.8%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 14,454 crore. The stock trades at a P/E of 36.0, below the industry P/E of 59.2. Looking ahead, the company is widening its digital and artificial intelligence services for life sciences clients and adding new customers across drug and device makers. Multi-year contracts with global clients support recurring revenue.
What risks should investors check before buying grid, space part and pharma service stocks?
Ans. Investors should check a few risks before buying grid, space part and pharma service stocks. Government spending. Public project funding can shift between periods. Order timing. Project awards can shift between periods. Client spending. Technology budgets can vary with global conditions. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of grid, space part and pharma service stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

3 Telecom IT Services Provider, Pistons Gaskets and Cooling Parts Maker and Medicines Exporter Stocks With a Strong Future Roadmap: Tech Mahindra, Banco Products (India) and Sun Pharma
17 November 2026

3 Airline Fare Software Provider, Visa Processing Firm and House Wires Producer Stocks With a Strong Future Roadmap: Accelya Solutions India, BLS International Services and RR Kabel
17 November 2026

3 Naval Shipbuilder, Diagnostics Centres Chain and Basmati Rice Company Stocks With a Strong Future Roadmap: Mazagon Dock Shipbuilders, Vijaya Diagnostic Centre and LT Foods
17 November 2026

3 Pathology Labs Network, Digital Engineering Firm and Stainless Pipes Maker Stocks With a Strong Future Roadmap: Thyrocare Technologies, Zensar Technologies and Ratnamani Metals and Tubes
17 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Telecom IT Services Provider, Pistons Gaskets and Cooling Parts Maker and Medicines Exporter Stocks With a Strong Future Roadmap: Tech Mahindra, Banco Products (India) and Sun Pharma
3 Airline Fare Software Provider, Visa Processing Firm and House Wires Producer Stocks With a Strong Future Roadmap: Accelya Solutions India, BLS International Services and RR Kabel
3 Naval Shipbuilder, Diagnostics Centres Chain and Basmati Rice Company Stocks With a Strong Future Roadmap: Mazagon Dock Shipbuilders, Vijaya Diagnostic Centre and LT Foods
3 Pathology Labs Network, Digital Engineering Firm and Stainless Pipes Maker Stocks With a Strong Future Roadmap: Thyrocare Technologies, Zensar Technologies and Ratnamani Metals and Tubes
3 Tablets and Capsules Exporter, Multi-Speciality Hospitals Chain and Cloud IT Services Provider Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Apollo Hospitals Enterprise and Mphasis

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





